A) Nf1 mRNA is expressed at higher level in differentiated osteoblasts (d4 to d10 of culture) than in TRAP+ multinucleated osteoclasts (qPCR).
B) Neurofibromin immunoreactivity (brown staining) in tibia periosteal and trabecular osteoblasts.
C) Nf1 cre recombination occurred in Nf1−/− osteoblasts (ob) and bones but not in osteoclasts (oc) or other cell types where Nf1 is expressed.
D and E) Increased bone volume/tissue volume (BV/TV), osteoblast surface/bone surface (ObS/BS), osteoblast number/bone perimeter (Ob.nb/BPm), and bone formation rate (BFR, μm3/μm2/year) in 3- (D) and 6-month-old (E) Nf1ob−/− mice (n = 6–9, p < 0.05).
F and G) Increased osteoid surface/bone surface (OS/BS), osteoid thickness (O. Th), trabecular thickness (Tb. Th), mineralization lag time (Mlt) (F), osteoclast surface/bone surface (Oc.S/BS), osteoclast number/bone perimeter (Oc.Nb/BPm), and urinary elimination of deoxypiridinoline (Dpd/creat.) (G) in 3-month-old mice Nf1ob−/− mice (n = 6–9, p < 0.05).
H and I) Number of TRAP-positive multinucleated osteoclasts (Oc. Nb, red staining) in osteoblasts (Ob)/osteoclasts (BMM) cocultures (H) and M-CSF and RANKL differentiated BMM cultures (n = 3, p < 0.05) (I).
J and K) α1(I) collagen (α1(I) coll, Tnsap (j, Northern), Atf4, Osterix (Osx), Runx2, and Osteocalcin (Ocn) ([K] qPCR) expression in WT and Nf1−/− osteoblasts (n > 3, p < 0.05).
L) Type 1(I) collagen content in WT, Nf1−/−, and Hyp bones and osteoblasts.
M) Collagen deposition (Van Gieson), alkaline phosphatase (Alk. Phos.) activity, and level in WT and Nf1−/− osteoblasts in culture (n = 3) and serum (n = 16, p < 0.05).
The data represent the mean ± the SEM.